Aprea Therapeutics, Inc.
USD0.82
+0.03 (+3.67%)
CEO
Oren Gilad
IPO Date
2019-10-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.78
Prev. Close
$0.79
Day Low
$0.78
Day High
$0.82
52W Low
$0.55
52W High
$2.22
Market Cap
$0.01B
Volume
0.06M
| -1.4 |
| 31 Dec 2023 | FY | 98.8% | -2449.6% | -78.2% | -63.1% | 0.00 | 5.14 | -1.2 |
| 31 Dec 2022 | FY | 0.0% | 0.0% | -439.3% | -373.6% | 0.00 | 9.42 | -0.0 |
| 31 Dec 2021 | FY | 0.0% | 0.0% | -73.8% | -64.3% | 0.00 | 7.73 | -1.7 |
| 31 Dec 2020 | FY | 0.0% | 0.0% | -69.7% | -58.1% | 0.00 | 6.03 | -1.9 |
| 31 Dec 2019 | FY | 0.0% | 0.0% | -22.6% | -21.0% | 0.00 | 14.68 | -32.9 |
| 31 Dec 2018 | FY | 0.0% | 0.0% | 30.2% | -23.5% | 0.00 | 13.56 | -18.6 |
| 31 Dec 2017 | FY | 0.0% | 0.0% | 42.5% | -61.3% | 0.00 | 5.75 | -19.0 |
| -0.7 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -25.5% | -20.8% | 0.00 | 5.20 | -0.8 |
| 30 Jun 2025 | Q2 | -1519.0% | -2742.2% | -24.1% | -18.7% | 0.00 | 5.34 | -0.8 |
| 31 Mar 2025 | Q1 | -1428.4% | -2420.6% | -25.3% | -19.4% | 0.00 | 5.90 | -0.8 |
| 31 Dec 2024 | Q4 | -1046.2% | -1406.5% | -15.0% | -12.1% | 0.00 | 7.01 | -1.7 |
| 30 Sept 2024 | Q3 | -702.7% | -1067.0% | -17.2% | -14.1% | 0.00 | 7.28 | -1.1 |
| 30 Jun 2024 | Q2 | -355.4% | -617.9% | -12.9% | -11.6% | 0.00 | 9.55 | -1.7 |
| 31 Mar 2024 | Q1 | -320.5% | -738.4% | -9.7% | -8.5% | 0.00 | 11.15 | -2.4 |
| 31 Dec 2023 | Q4 | -14434.2% | -24463.6% | -18.9% | -15.2% | 0.00 | 5.14 | -1.3 |